[Future targets in the treatment of type 2 diabetes].

about

[Future targets in the treatment of type 2 diabetes].

Item

http://www.wikidata.org/entity/Q44896352

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh

2004年學術文章

@zh-hant

name

[Future targets in the treatment of type 2 diabetes].

@en

[Future targets in the treatment of type 2 diabetes].

@nl

type

Item

label

[Future targets in the treatment of type 2 diabetes].

@en

[Future targets in the treatment of type 2 diabetes].

@nl

prefLabel

[Future targets in the treatment of type 2 diabetes].

@en

[Future targets in the treatment of type 2 diabetes].

@nl

P1476

[Future targets in the treatment of type 2 diabetes].

@en

P2093

Harald Stingl

http://www.w3.org/2001/XMLSchema#string

Michael Roden

http://www.w3.org/2001/XMLSchema#string

P2860

Role of AMP-activated protein kinase in mechanism of metformin action

Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes

Prevention of fat-induced insulin resistance by salicylate

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy.

The long-acting GLP-1 derivative NN2211 ameliorates glycemia and increases beta-cell mass in diabetic mice.

Effects of 1-mo bolus subcutaneous administration of exendin-4 in type 2 diabetes.

Dual PPARalpha /gamma activation provides enhanced improvement of insulin sensitivity and glycemic control in ZDF rats.

PPARalpha /gamma ragaglitazar eliminates fatty liver and enhances insulin action in fat-fed rats in the absence of hepatomegaly.

Combination therapy with PPARgamma and PPARalpha agonists increases glucose-stimulated insulin secretion in db/db mice.

P2888

bf03041051

P304

217-229

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/BF03041051

http://www.w3.org/2001/XMLSchema#string

P407

Af-Jarmal

P433

7-8

http://www.w3.org/2001/XMLSchema#string

P478

116

http://www.w3.org/2001/XMLSchema#string

P577

2004-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15143860

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes